Pre-Screening Committee Meetings

Thursday, February 22, 2024

1 PM Pacific / 4 PM Eastern

Genomate Health

Join CANCER FUND’s Pre-Screening Committee Zoom meeting with Genomate Health to learn more about their computational reasoning AI-enabled precision oncology solution aiming to predict cancer patient responses to molecularly targeted therapies by analyzing millions of genetic biomarker combinations. Unlike traditional approaches focusing on single biomarkers, Genomate generates a prioritized list of potential therapies based on multiple genetic driver alterations and biomarkers present in each tumor.